United States · FDA National Drug Code directory
Erythromycin Ethylsuccinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75834-295_7f06e8f4-15fb-4e18-b57e-457e7e20d331
- Product NDC
- 75834-295
- Form
- SUSPENSION
- Composition / generic term
- Erythromycin Ethylsuccinate
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230201
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN ETHYLSUCCINATE — 200 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (75834-295-01) · 75834-295-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →